|
|
Research Management and Support
|
RMS ES 2018
|
$340,640,887
|
$388,700
|
N/A
|
National Institutes of Health
|
|
|
IGF::OT::IGF Topic 378: mPROS: Mobile PRO-CTCAE Administration System for Post-Radiation Toxicities
|
261201800013C
|
$224,995
|
$112,498
|
-, -
|
INTELLIGENT AUTOMATION, INC.
|
|
|
NCI AT FREDERICK IAA WITH DEFENSE BIOLOGICAL PRODUCT ASSURANCE OFFICE (DBPAO)
|
ACO18006-001
|
$1,367
|
$1,367
|
-, -
|
UNITED STATES DEPARTMENT OF DE
|
|
|
IAA WITH VA FOR PREDICTION TOOLS FOR HEAD AND NECK CANCERS
|
APC18006-001
|
$15,000
|
$15,000
|
-, -
|
VETERANS HEALTH ADMINISTRATION
|
|
|
Developing targeted activatable peptides to amplify radiosensitizer delivery
|
5R03CA219744-02
|
$77,500
|
$77,500
|
ADVANI, SUNIL
|
UNIVERSITY OF CALIFORNIA, SAN DIEGO
|
|
|
Quantitative Radiomics System Decoding the Tumor Phenotype
|
5U24CA194354-04
|
$683,694
|
$341,847
|
AERTS, HUGO
|
DANA-FARBER CANCER INST
|
|
|
Network Lead Academic Participating Site: Memorial Sloan-Kettering Cancer Center
|
3U10CA180791-04S1
|
$145,357
|
$7,268
|
AGHAJANIAN, CAROL
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
|
Network Lead Academic Participating Site: Memorial Sloan-Kettering Cancer Center
|
5U10CA180791-05
|
$922,200
|
$46,110
|
AGHAJANIAN, CAROL
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
|
Functional Determinants of Metastatic Dormancy
|
5R01CA109182-15
|
$423,844
|
$423,844
|
AGUIRRE-GHISO, JULIO
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
|
Epigenetic and microenvironmental regulation of dormant disseminated cancer
|
5R01CA218024-02
|
$428,136
|
$428,136
|
AGUIRRE-GHISO, JULIO
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
|
Clinical translation of 19F MRI to visualize cancer immunotherapeutic cells
|
5R01CA134633-06
|
$535,071
|
$535,071
|
AHRENS, ERIC
|
UNIVERSITY OF CALIFORNIA, SAN DIEGO
|
|
|
Naional Cancer Institute, Naitonal Clinical Trials Network U10 Lead Academic Site
|
5U10CA180790-05
|
$1,223,634
|
$36,709
|
ALBERTS, STEVEN
|
MAYO CLINIC ROCHESTER
|
|
|
Inherited bone marrow failure syndromes study
|
ZIA CP010144 07130
|
$1,652,758
|
$462,773
|
Alter, Blanche
|
DCEG (NCI)
|
|
|
Consolidated Basic Cancer Research Program
|
3P30CA010815-49S1
|
$142,498
|
$1,425
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
|
Consolidated Basic Cancer Research Program
|
3P30CA010815-49S2
|
$200,000
|
$2,000
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
|
Consolidated Basic Cancer Research Program
|
5P30CA010815-49
|
$2,645,581
|
$26,456
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
|
HIV/HPV Cancer Prevention, Treatment & Pathogenesis: Rwanda/Einstein Consortium
|
5U54CA190163-05
|
$701,988
|
$14,040
|
ANASTOS, KATHRYN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
|
Hutchinson Center as Lead Academic Participating Site (U10)
|
5U10CA180828-05
|
$605,293
|
$30,265
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
|
Stanford Cancer Institute
|
3P30CA124435-11S1
|
$248,520
|
$2,485
|
ARTANDI, STEVEN
|
STANFORD UNIVERSITY
|
|
|
Stanford Cancer Institute
|
3P30CA124435-11S2
|
$171,518
|
$1,715
|
ARTANDI, STEVEN
|
STANFORD UNIVERSITY
|
|
|
Stanford Cancer Institute
|
5P30CA124435-11
|
$3,334,464
|
$33,345
|
ARTANDI, STEVEN
|
STANFORD UNIVERSITY
|
|
|
Cancer Center Support Grant - UT Southwestern Medical Center
|
3P30CA142543-09S1
|
$249,371
|
$4,987
|
ARTEAGA, CARLOS
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
|
Cancer Center Support Grant - UT Southwestern Medical Center
|
5P30CA142543-09
|
$2,480,000
|
$49,600
|
ARTEAGA, CARLOS
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
|
Optimizing cancer photodynamic therapy using photoacoustic lifetime imaging
|
5R01CA183749-04
|
$323,272
|
$323,272
|
ASHKENAZI, SHAI
|
UNIVERSITY OF MINNESOTA
|
|
|
Cancer Center Support Grant
|
2P30CA082103-19
|
$7,954,381
|
$238,631
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
|
Cancer Center Support Grant
|
3P30CA082103-19S1
|
$84,000
|
$2,520
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
|
Cancer Center Support Grant
|
3P30CA082103-19S2
|
$206,488
|
$6,195
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
|
Cancer Center Support Grant
|
3P30CA082103-19S3
|
$257,838
|
$7,735
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
|
Synergistic targeting of cholesterol metabolism and EGFR signaling in cancer
|
5R01CA188430-05
|
$379,725
|
$189,862
|
ASTSATUROV, IGOR
|
RESEARCH INST OF FOX CHASE CAN CTR
|
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
2P30CA014520-44
|
$4,590,130
|
$183,605
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
3P30CA014520-44S1
|
$250,000
|
$10,000
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
3P30CA014520-44S2
|
$136,232
|
$5,449
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
3P30CA014520-44S3
|
$75,711
|
$3,028
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
3P30CA014520-44S4
|
$31,772
|
$1,271
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
|
Anatomic Pathology Residency Program
|
ZIE BC 011384
|
$1,537,925
|
$107,655
|
Barr, Frederic
|
CCR (NCI)
|
|
|
Washington University/ Siteman Cancer Center Lead Academic Site
|
5U10CA180833-05
|
$1,394,352
|
$69,718
|
BARTLETT, NANCY
|
WASHINGTON UNIVERSITY
|
|
|
Therapeutic targeting of Fibroblast Growth Factor Receptors in Squamous Cancers
|
5R01CA196932-04
|
$387,027
|
$193,514
|
BASS, ADAM
|
DANA-FARBER CANCER INST
|
|
|
Mortality among formaldehyde workers
|
ZIA CP010120 02100
|
$42,287
|
$12,686
|
Beane Freeman, Laura
|
DCEG (NCI)
|
|
|
Vanderbilt Network Lead Academic Participating Site for the NCTN
|
5U10CA180847-06
|
$503,410
|
$25,170
|
BERLIN, JORDAN
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
|
Johns Hopkins University NCTN Lead Academic Site Program
|
5U10CA180802-05
|
$575,595
|
$28,780
|
BRAHMER, JULIE
|
JOHNS HOPKINS UNIVERSITY
|
|
|
Rapid, quantitative and affordable point-of-care diagnostics for oral and oropharyngeal cancer
|
1R43CA228815-01A1
|
$299,917
|
$299,917
|
BRAND, CHRISTIAN
|
SUMMIT BIOMEDICAL IMAGING, LLC
|
|
|
Biomarkers of human papillomavirus (HPV) infection and risk of two increasing cancers
|
5U01CA195603-04
|
$443,239
|
$221,620
|
BRENNAN, PAUL
|
INTERNATIONAL AGENCY FOR RES ON CANCER
|
|
|
Oncogenic Kinases in Cancer
|
ZIA BC 011691
|
$823,702
|
$329,481
|
Brognard, John
|
CCR (NCI)
|
|
|
NCI NCTN-Network Lead Academic Site at UPCI
|
5U10CA180844-05
|
$898,424
|
$44,921
|
BRUFSKY, ADAM
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
|
Quantitative Imaging to Assess Response in Cancer Therapy Trials
|
5U01CA140206-09
|
$622,467
|
$311,234
|
BUATTI, JOHN
|
UNIVERSITY OF IOWA
|
|
|
The Dynamics of Smoking Cessation After Cancer Diagnosis: A Naturalisitic Study
|
5K07CA181351-05
|
$153,314
|
$153,314
|
BURRIS, JESSICA
|
UNIVERSITY OF KENTUCKY
|
|
|
NCTN Lead Academic Participating Site at Dana-Farber/Partners Cancer Care
|
5U10CA180867-05
|
$1,302,199
|
$32,555
|
BURSTEIN, HAROLD
|
DANA-FARBER CANCER INST
|
|
|
Stable Water Isotope Labeling for Imaging of Rapidly Proliferating Cells
|
ZIA BC 011777
|
$32,855
|
$1,971
|
Buxbaum, Nataliya
|
CCR (NCI)
|
|
|
A novel point of care test for oral and oropharyngeal cancer risk
|
5R01CA204264-02
|
$554,293
|
$554,293
|
CALIFANO, JOSEPH
|
UNIVERSITY OF CALIFORNIA, SAN DIEGO
|
|
|
Optimizing an assay for high risk HPV DNA in body fluids
|
5UH2CA211396-02
|
$270,302
|
$135,151
|
CALIFANO, JOSEPH
|
UNIVERSITY OF CALIFORNIA, SAN DIEGO
|
|
Total relevant funding to Head and Neck for this search: $62,087,838
|
